BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8253534)

  • 1. Effect of epidermal growth factor and transforming growth factor beta 1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines.
    Kawamata H; Kameyama S; Nan L; Kawai K; Oyasu R
    Int J Cancer; 1993 Dec; 55(6):968-73. PubMed ID: 8253534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
    Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
    Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro.
    Tamatani T; Hattori K; Iyer A; Tamatani K; Oyasu R
    Carcinogenesis; 1999 Jun; 20(6):957-62. PubMed ID: 10357773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.
    Kondapaka SB; Fridman R; Reddy KB
    Int J Cancer; 1997 Mar; 70(6):722-6. PubMed ID: 9096655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A.
    Kawamata H; Kameyama S; Kawai K; Tanaka Y; Nan L; Barch DH; Stetler-Stevenson WG; Oyasu R
    Int J Cancer; 1995 Nov; 63(4):568-75. PubMed ID: 7591268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells.
    De Boer WI; Houtsmuller AB; Izadifar V; Muscatelli-Groux B; Van der Kwast TH; Chopin DK
    Int J Cancer; 1997 Apr; 71(2):284-91. PubMed ID: 9139855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes.
    Game SM; Huelsen A; Patel V; Donnelly M; Yeudall WA; Stone A; Fusenig NE; Prime SS
    Int J Cancer; 1992 Sep; 52(3):461-70. PubMed ID: 1328069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.
    Graham CH; Connelly I; MacDougall JR; Kerbel RS; Stetler-Stevenson WG; Lala PK
    Exp Cell Res; 1994 Sep; 214(1):93-9. PubMed ID: 8082752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma.
    Gleave ME; Hsieh JT; Wu HC; Hong SJ; Zhau HE; Guthrie PD; Chung LW
    Cancer Res; 1993 Nov; 53(21):5300-7. PubMed ID: 8221665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells.
    Theodorescu D; Cornil I; Sheehan C; Man MS; Kerbel RS
    Cancer Res; 1991 Aug; 51(16):4486-91. PubMed ID: 1868471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma.
    Kawamata H; Kawai K; Kameyama S; Johnson MD; Stetler-Stevenson WG; Oyasu R
    Int J Cancer; 1995 Nov; 63(5):680-7. PubMed ID: 7591285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells.
    Itoh M; Murata T; Suzuki T; Shindoh M; Nakajima K; Imai K; Yoshida K
    Oncogene; 2006 Feb; 25(8):1195-204. PubMed ID: 16205632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour progression in experimental oral carcinogenesis is associated with changes in EGF and TGF-beta receptor expression and altered responses to these growth factors.
    Game SM; Stone A; Scully C; Prime SS
    Carcinogenesis; 1990 Jun; 11(6):965-73. PubMed ID: 2161297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraluminal epidermal growth factor affects growth of N-methyl-N-nitrosourea-initiated rat bladder carcinoma.
    Kawai K; Kawamata H; Kameyama S; Rademaker A; Oyasu R
    Jpn J Cancer Res; 1995 May; 86(5):429-34. PubMed ID: 7790316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.